Ashok Balasubramanyam

Summary

Affiliation: Texas Christian University
Country: USA

Publications

  1. ncbi request reprint Cardiovascular event prevention in the person with type 2 diabetes: case examples for identifying and treating multiple risks
    Ashok Balasubramanyam
    Baylor College of Medicine, One Baylor Plaza, Room 719E, Houston, TX 77030, USA
    Diabetes Educ 32:163S-173S; quiz 174S-177S. 2006
  2. ncbi request reprint Long-term, randomized clinical trial of two diets in the metabolic syndrome and type 2 diabetes
    Lynne W Scott
    Diabetes Care 26:2481-2. 2003
  3. ncbi request reprint Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome
    Gilbert G Fareau
    Translational Metabolism Unit, Division of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, Houston, TX 77030, USA
    Metabolism 56:670-5. 2007
  4. ncbi request reprint Case study
    James R LaSalle
    Medical Arts Research Collaborative, Excelsior Springs, Missouri, USA
    Am J Manag Care 12:S392. 2006
  5. ncbi request reprint Health outcomes beyond glucose control
    Ashok Balasubramanyam
    Translational Metabolism Unit, Division of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, Houston, Texas, USA
    Am J Manag Care 12:S382-91. 2006
  6. ncbi request reprint Presence of the metabolic syndrome distinguishes patients with ketosis-prone diabetes who have a Type 2 diabetic phenotype
    Max E Otiniano
    Division of Endocrinology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    J Diabetes Complications 19:313-8. 2005
  7. ncbi request reprint Accelerometer feedback to promote physical activity in adults with type 2 diabetes: a pilot study
    Antonia A Paschali
    Psychology Department, University of Athens
    Percept Mot Skills 100:61-8. 2005
  8. ncbi request reprint Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability
    Abu R Vasudevan
    Division of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, Houston, Texas 77030, USA
    Diabetes Technol Ther 6:850-63. 2004
  9. ncbi request reprint Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of 'systemic steatosis'
    Ashok Balasubramanyam
    Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA
    Curr Opin Lipidol 15:59-67. 2004
  10. ncbi request reprint Novel syndromes of ketosis-prone diabetes: implications for management and medical economics
    Ashok Balasubramanyam
    Endocrine Service, Ben Taub General Hospital, Baylor College of Medicine, Houston, USA
    Manag Care 13:7-10; discussion 19-21. 2004

Collaborators

  • William Polonsky
  • Christie Ballantyne
  • Max E Otiniano
  • Peter H Jones
  • Mario Maldonado
  • Ramaswami Nalini
  • Gilbert G Fareau
  • James R LaSalle
  • Antonia A Paschali
  • Rajagopal V Sekhar
  • Abu R Vasudevan
  • Dinakar Iyer
  • Lucille Rodriguez
  • Lynne W Scott
  • Mario R Maldonado
  • Susana D'Amico
  • Elif Oral
  • Anastasia Kalantzi-Azizi
  • Danai Papadatou
  • G Kenneth Goodrick
  • Henry J Pownall
  • Farook Jahoor
  • Lisa P Hammerle
  • Arun Rajan
  • Amy K Aherns
  • Douglas Bolgiano
  • Lakshmi K Gaur
  • Ake Lernmark
  • C Michael Fordis
  • Christiane S Hampe
  • Kay T Kimball

Detail Information

Publications14

  1. ncbi request reprint Cardiovascular event prevention in the person with type 2 diabetes: case examples for identifying and treating multiple risks
    Ashok Balasubramanyam
    Baylor College of Medicine, One Baylor Plaza, Room 719E, Houston, TX 77030, USA
    Diabetes Educ 32:163S-173S; quiz 174S-177S. 2006
  2. ncbi request reprint Long-term, randomized clinical trial of two diets in the metabolic syndrome and type 2 diabetes
    Lynne W Scott
    Diabetes Care 26:2481-2. 2003
  3. ncbi request reprint Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome
    Gilbert G Fareau
    Translational Metabolism Unit, Division of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, Houston, TX 77030, USA
    Metabolism 56:670-5. 2007
    ..We have documented, for the first time, regression of AN in temporal association with disappearance of circulating anti-insulin receptor autoantibodies and achievement of euglycemia in a patient with type B insulin resistance...
  4. ncbi request reprint Case study
    James R LaSalle
    Medical Arts Research Collaborative, Excelsior Springs, Missouri, USA
    Am J Manag Care 12:S392. 2006
  5. ncbi request reprint Health outcomes beyond glucose control
    Ashok Balasubramanyam
    Translational Metabolism Unit, Division of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, Houston, Texas, USA
    Am J Manag Care 12:S382-91. 2006
    ....
  6. ncbi request reprint Presence of the metabolic syndrome distinguishes patients with ketosis-prone diabetes who have a Type 2 diabetic phenotype
    Max E Otiniano
    Division of Endocrinology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    J Diabetes Complications 19:313-8. 2005
    ..This study was designed to determine if patients with ketosis-prone diabetes could be distinguished clinically on the basis of features of the metabolic syndrome (MetS)...
  7. ncbi request reprint Accelerometer feedback to promote physical activity in adults with type 2 diabetes: a pilot study
    Antonia A Paschali
    Psychology Department, University of Athens
    Percept Mot Skills 100:61-8. 2005
    ..Further studies with larger sample sizes and greater control of experimental conditions are needed to determine the utility of objective activity feedback...
  8. ncbi request reprint Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability
    Abu R Vasudevan
    Division of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, Houston, Texas 77030, USA
    Diabetes Technol Ther 6:850-63. 2004
    ....
  9. ncbi request reprint Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of 'systemic steatosis'
    Ashok Balasubramanyam
    Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA
    Curr Opin Lipidol 15:59-67. 2004
    ..Identification of rationally based therapies requires an understanding of the mechanistic basis of HADL...
  10. ncbi request reprint Novel syndromes of ketosis-prone diabetes: implications for management and medical economics
    Ashok Balasubramanyam
    Endocrine Service, Ben Taub General Hospital, Baylor College of Medicine, Houston, USA
    Manag Care 13:7-10; discussion 19-21. 2004
  11. ncbi request reprint Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy
    Rajagopal V Sekhar
    Division of Endocrinology, Baylor College of Medicine, 719E, One Baylor Plaza, Houston, TX 77030, USA
    Curr Atheroscler Rep 6:173-9. 2004
    ..In this article, we review HADL in terms of metabolic, molecular, and cytokine derangements leading to cardiovascular disease...
  12. ncbi request reprint Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes
    Mario Maldonado
    Division of Endocrinology, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
    J Clin Endocrinol Metab 88:5090-8. 2003
    ..Novel, nonautoimmune causes of beta-cell dysfunction are likely to underlie the A-beta+ and A-beta- syndromes...
  13. ncbi request reprint Improved outcomes in indigent patients with ketosis-prone diabetes: effect of a dedicated diabetes treatment unit
    Mario R Maldonado
    Section of Endocrinology, Department of Medicine, Baylor College of Medicine, and Ben Taub General Hospital, Houston, Texas 77030 3498, USA
    Endocr Pract 9:26-32. 2003
    ..To investigate whether a specialized intervention program could improve diabetes-related health outcomes in indigent patients with type 1 diabetes who were prone to occurrence of diabetic ketoacidosis (DKA)...
  14. ncbi request reprint Re: A comparison of classification schemes for ketosis-prone diabetes
    Ramaswami Nalini
    Division of Diabetes, Endocrinology and Metabolism, N520 Alkek, One Baylor Plaza, Baylor College of Medicine, Houston, TX 77030, USA
    Nat Clin Pract Endocrinol Metab 3:E1. 2007